Shandong Sinobioway Biomedicine Co.,Ltd. Posted 868,191 Yuan Net Loss in 2022
Listen to the full version

Shandong Sinobioway Biomedicine Co.,Ltd. (山东未名生物医药股份有限公司) (002581.SZ) reported a net loss of 868,191 yuan in 2022, reversing a net profit of 278.7 million yuan for the previous year.
Meanwhile, the company posted 357.1 million yuan in revenue, down 11.3% year-on-year.
At the end of the reporting period, it had 2.9 billion yuan in total assets and 389.5 million yuan in total liabilities, with a liability-to-asset ratio of 13.6%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR